Swan Lin

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Venues

Clinical and translational science

Cancer chemotherapy and pharmacology

European journal of drug metabolism and pharmacokinetics

Pfizer Global Research and Development La Jolla

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Global Research and Development La Jolla Dec 04 2017

United States

Clinical Pharmacologist :: Clinical Pharmacology/Pharmacometrics

Publications

Swan Lin, Adrian Ionescu, Jessica Maynard-Scott, Mike Kennedy, David P Walling, Maura Furey, Jaskaran B Singh
Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults. Clinical and translational science 17 (5) (2024)
Swan Lin, Adrian Ionescu, Jessica Maynard-Scott, Mike Kennedy, David P Walling, Maura Furey, Jaskaran B Singh
Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults. Clinical and translational science 17 (5) (2024)
Swan Lin, Adrian Ionescu, Jessica Maynard-Scott, Mike Kennedy, David P Walling, Maura Furey, Jaskaran B Singh
Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults. Clinical and translational science 17 (5) (2024)
Swan Lin, Jason Gong, George C Canas, Peter Winkle, Kathleen Pelletier, Robert R LaBadie, Katherine Ginman, Yazdi K Pithavala
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment. European journal of drug metabolism and pharmacokinetics 47 (2) (2022)
Swan Lin, Naveed Shaik, Geoffrey Chan, Jorge E Cortes, Ana Ruiz-Garcia
An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure. Cancer chemotherapy and pharmacology 86 (4) (2020)

Swan Lin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Swan Lin